SurgePays, Inc. (NASDAQ:SURG) CEO Kevin Brian Cox Sells 35,180 Shares

SurgePays, Inc. (NASDAQ:SURGGet Free Report) CEO Kevin Brian Cox sold 35,180 shares of the business’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1.82, for a total value of $64,027.60. Following the completion of the sale, the chief executive officer now directly owns 5,770,090 shares in the company, valued at $10,501,563.80. This trade represents a 0.61 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

SurgePays Trading Up 1.1 %

SURG stock opened at $1.86 on Thursday. SurgePays, Inc. has a 1-year low of $1.33 and a 1-year high of $9.23. The business has a fifty day moving average price of $1.76 and a 200-day moving average price of $2.40. The company has a debt-to-equity ratio of 0.08, a quick ratio of 4.70 and a current ratio of 6.24.

SurgePays (NASDAQ:SURGGet Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The medical equipment provider reported ($0.73) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.51). SurgePays had a negative return on equity of 55.63% and a negative net margin of 27.39%. The business had revenue of $4.77 million during the quarter, compared to analysts’ expectations of $8.64 million. During the same quarter in the prior year, the firm earned $0.49 EPS. On average, equities research analysts anticipate that SurgePays, Inc. will post -1.34 EPS for the current year.

SurgePays declared that its board has authorized a stock buyback program on Tuesday, August 13th that allows the company to repurchase $5.00 million in shares. This repurchase authorization allows the medical equipment provider to buy up to 14.8% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets dropped their target price on SurgePays from $9.50 to $9.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th.

Get Our Latest Stock Analysis on SURG

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its position in SurgePays by 8.2% during the first quarter. Vanguard Group Inc. now owns 505,380 shares of the medical equipment provider’s stock valued at $1,946,000 after acquiring an additional 38,195 shares during the last quarter. National Bank of Canada FI increased its position in SurgePays by 50.0% during the second quarter. National Bank of Canada FI now owns 36,000 shares of the medical equipment provider’s stock valued at $111,000 after acquiring an additional 12,000 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in SurgePays during the second quarter valued at $45,000. Dimensional Fund Advisors LP increased its position in SurgePays by 49.0% during the second quarter. Dimensional Fund Advisors LP now owns 24,331 shares of the medical equipment provider’s stock valued at $78,000 after acquiring an additional 7,998 shares during the last quarter. Finally, Corsair Capital Management L.P. increased its position in SurgePays by 50.3% during the third quarter. Corsair Capital Management L.P. now owns 29,864 shares of the medical equipment provider’s stock valued at $55,000 after acquiring an additional 10,000 shares during the last quarter. Hedge funds and other institutional investors own 6.94% of the company’s stock.

SurgePays Company Profile

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Read More

Insider Buying and Selling by Quarter for SurgePays (NASDAQ:SURG)

Receive News & Ratings for SurgePays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurgePays and related companies with MarketBeat.com's FREE daily email newsletter.